Professor Janet Shipley, Research Advisory Committee, Sarcoma UK

Professor Shipley’s research is focused on identifying molecular markers of high-risk in young onset sarcomas and understanding associated molecular mechanisms in order to derive novel treatments for these patients. She leads the Sarcoma Molecular Pathology Team at the Institute of Cancer Research. 

She is a member of the of the National Cancer Research Institute (NCRI) Clinical Studies Young Onset Sarcoma Subgroup (YOSS); and is Chair of the Biological Committee for the European paediatric Soft tissue sarcoma Study Group (EpSSG).

She has authored more than 160 peer-reviewed papers.